Skip to content
Search

Latest Stories

SaveourPharmacies: Two thirds of pharmacies forced to slash opening hours due to funding squeeze

SaveourPharmacies: Two thirds of pharmacies forced to slash opening hours due to funding squeeze
Pharmacy protest unveils as up to 6000 pharmacies through NPA have called for a day of action against financial crisis burdening the sector

"Cutting opening hours is a last resort for pharmacies desperately trying to make ends meet in the face of a decade of cuts," Paul Rees, Chief Executive of the National Pharmacy Association(NPA) has stated.

Amidst unprecedented closures and financial strain, up to 6,000 community pharmacies across the UK unite in protest today, underscoring a decade of funding cuts that have forced two-thirds to slash operating hours, highlighting a sector in crisis.


The unprecedented day of action is symbolized by dimming lights and wearing black to protest against the deteriorating financial conditions.

According to new analysis by the NPA, approximately 63 per cent of pharmacies have been compelled to reduce their opening hours since 2015 due to extreme financial pressures.

This translates to an average reduction of 6.1 hours per pharmacy, amounting to a 10 per cent decrease in accessibility for patients.

The analysis further reveals that only a minuscule 2.5 per cent of pharmacies managed to increase their operating hours during this period.

In 2015, pharmacies were open an average of 54.2 hours per week, a number that has dwindled to 48.1 hours by 2024.

Additionally, nearly 5 per cent of pharmacies included in the study were forced to shut down completely.

Funding for pharmacies in England alone has plummeted by 40 per cent in real terms over the past decade, pushing many establishments to the brink of closure.

Paul Rees, Chief Executive of the NPA, conveyed the gravity of the situation, stating, "The current situation is unsustainable and, with three-quarters of pharmacies in the red, many are simply being pushed to the brink."

He emphasized the dire consequences, noting that 1,400 pharmacies have shut down in England alone over the last ten years, with similar closures in Wales and Northern Ireland, and impending risks in Scotland.

The NPA's February survey underscored that 64 per cent of pharmacy owners are tapping into personal savings or family support to sustain their businesses, with 79 per cent reporting inadequate remuneration for their work.

This financial strain is exacerbated by the fact that pharmacy funding no longer covers the costs of many medicines, forcing pharmacies to dispense medication at a loss.

Rees highlighted the urgency for political intervention, calling for a new funding framework that allocates at least 2.5 per cent of the overall NHS budget to pharmacies.

The NPA's day of action aims to draw attention to these issues, urging all political parties to commit to ending funding reductions and ensuring a sustainable future for community pharmacies.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less